BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36326752)

  • 1. Prevalence of Age-Related Macular Degeneration in the US in 2019.
    Rein DB; Wittenborn JS; Burke-Conte Z; Gulia R; Robalik T; Ehrlich JR; Lundeen EA; Flaxman AD
    JAMA Ophthalmol; 2022 Dec; 140(12):1202-1208. PubMed ID: 36326752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Diabetic Retinopathy in the US in 2021.
    Lundeen EA; Burke-Conte Z; Rein DB; Wittenborn JS; Saaddine J; Lee AY; Flaxman AD
    JAMA Ophthalmol; 2023 Aug; 141(8):747-754. PubMed ID: 37318810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine eye examinations for persons 20-64 years of age: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(15):1-81. PubMed ID: 23074485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis.
    Flaxman AD; Wittenborn JS; Robalik T; Gulia R; Gerzoff RB; Lundeen EA; Saaddine J; Rein DB;
    JAMA Ophthalmol; 2021 Jul; 139(7):717-723. PubMed ID: 33983373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008.
    Zhu Z; Wang W; Keel S; Zhang J; He M
    JAMA Ophthalmol; 2019 Mar; 137(3):248-257. PubMed ID: 30570662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER.
    Muñoz B; Klein R; Rodriguez J; Snyder R; West SK
    Arch Ophthalmol; 2005 Nov; 123(11):1575-80. PubMed ID: 16286621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of age-related macular degeneration in the United States.
    Friedman DS; O'Colmain BJ; Muñoz B; Tomany SC; McCarty C; de Jong PT; Nemesure B; Mitchell P; Kempen J;
    Arch Ophthalmol; 2004 Apr; 122(4):564-72. PubMed ID: 15078675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on the Epidemiology of Age-Related Macular Degeneration.
    Jonas JB; Cheung CMG; Panda-Jonas S
    Asia Pac J Ophthalmol (Phila); 2017; 6(6):493-497. PubMed ID: 28906084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-Related Macular Degeneration and Quality of Life in Latinos: The Los Angeles Latino Eye Study.
    Choudhury F; Varma R; Klein R; Gauderman WJ; Azen SP; McKean-Cowdin R;
    JAMA Ophthalmol; 2016 Jun; 134(6):683-90. PubMed ID: 27124819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
    Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study.
    Varma R; Fraser-Bell S; Tan S; Klein R; Azen SP;
    Ophthalmology; 2004 Jul; 111(7):1288-97. PubMed ID: 15234128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related macular degeneration: prevalence and risk factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011.
    Park SJ; Lee JH; Woo SJ; Ahn J; Shin JP; Song SJ; Kang SW; Park KH;
    Ophthalmology; 2014 Sep; 121(9):1756-65. PubMed ID: 24813632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(13):1-22. PubMed ID: 23074517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Age-Related Macular Degeneration in Chinese American Adults: The Chinese American Eye Study.
    Varma R; Choudhury F; Chen S; Wu S; Hsu C; Torres M; Klein R; Azen SP; McKean-Cowdin R;
    JAMA Ophthalmol; 2016 May; 134(5):571-577. PubMed ID: 27055183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the Diagnosed Prevalence and Incidence of Major Eye Diseases in Medicare Part B Fee-for-Service Beneficiaries 68 Years of Age or Older.
    Ehrlich JR; Andes LJ; Eisenberg A; Saaddine J; Lundeen EA
    Ophthalmology; 2023 Dec; 130(12):1240-1247. PubMed ID: 37495083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
    Liisborg C
    Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of age-related macular degeneration in the US population.
    Klein R; Chou CF; Klein BE; Zhang X; Meuer SM; Saaddine JB
    Arch Ophthalmol; 2011 Jan; 129(1):75-80. PubMed ID: 21220632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Age-Related Macular Degeneration in Australia: The Australian National Eye Health Survey.
    Keel S; Xie J; Foreman J; van Wijngaarden P; Taylor HR; Dirani M
    JAMA Ophthalmol; 2017 Nov; 135(11):1242-1249. PubMed ID: 29049463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL; Yu F
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.